中環控股(01735.HK)擬無償收購珠海中環雲健康管理全部股權
格隆匯3月19日丨中環控股(01735.HK)發佈公告,2020年3月19日,公司間接全資附屬公司中環雲智健康科技(浙江)有限公司(“買方”)、浙江中環農業開發有限公司及執行董事、董事會主席兼控股股東餘竹雲(連同浙江中環統稱“賣方”)訂立一份股份轉讓協議,據此,買方同意無償購買而賣方同意無償出售一間於中國成立的公司珠海中環雲健康管理有限公司全部股權。
根據披露,公司珠海中環雲健康管理有限公司的業務範疇主要包括根據商業牌照提供健康相關服務,於該公告日期,該公司並無業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.